Literature DB >> 16503320

Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia.

Ilene H Zuckerman1, Jose Josue Hernandez, Ann L Gruber-Baldini, J Richard Hebel, Bruce Stuart, Sheryl Zimmerman, Jay Magaziner.   

Abstract

OBJECTIVES: This study was designed to describe changes in the prevalence of potentially inappropriate medication prescribing before and after nursing home admission, and to compare prevalence among residents with and without dementia. This paper extends the research on inappropriate medication prescribing among residents entering a nursing home, with the added feature of comparison by dementia status.
METHODS: This retrospective cohort study was conducted using data from 59 randomly selected nursing homes in Maryland. Dually eligible (Medicare/Medicaid) residents aged > or = 65 years who were admitted to one of these nursing homes from 1992 to 1995 were eligible for inclusion in the cohort. An expert panel of physicians determined dementia status at admission. Potentially inappropriate prescribing, as defined by the 1997 Beers criteria, was compared using Medicaid prescription claims for up to 12 months before and after admission to characterize monthly prescribing patterns.
RESULTS: The study group included 546 dually eligible nursing home residents with > or = 1 paid prescription claim for the 12 months before or after their admission date. A total of 372 (68%) residents were white, 443 (81%) were unmarried, 408 (75%) were female, and 334 (61%) were diagnosed with dementia at admission. Before nursing home admission, the mean monthly prevalence of potentially inappropriate medications for residents with and without dementia was 20% and 23%, respectively. After admission, the mean monthly prevalence increased to 28% among residents without dementia and decreased to 19% among residents with dementia. After adjusting for the mean number of other prescriptions, sociodemographic factors, and number of comorbid conditions, residents with dementia were as likely as residents without dementia to receive a potentially inappropriate drug before admission (prevalence ratio, 0.97; 95% CI, 0.58-1.62). After admission, residents with dementia were 27% less likely than residents without dementia to receive a potentially inappropriate drug, although the difference did not reach statistical significance (prevalence ratio, 0.73; 95% CI, 0.53-1.01).
CONCLUSIONS: Inappropriate medication prescribing was similar before nursing home admission among patients with and without dementia. After admission, the prevalence was lower among residents with dementia, but it did not reach statistical significance.

Entities:  

Mesh:

Year:  2005        PMID: 16503320     DOI: 10.1016/j.amjopharm.2005.12.007

Source DB:  PubMed          Journal:  Am J Geriatr Pharmacother        ISSN: 1876-7761


  13 in total

1.  The impact of family caregivers on potentially inappropriate medication use in noninstitutionalized older adults with dementia.

Authors:  Joshua M Thorpe; Carolyn T Thorpe; Korey A Kennelty; Walid F Gellad; Richard Schulz
Journal:  Am J Geriatr Pharmacother       Date:  2012-06-09

2.  Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database.

Authors:  François Montastruc; Cannelle Duguet; Vanessa Rousseau; Haleh Bagheri; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2014-06-14       Impact factor: 2.953

3.  Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France.

Authors:  Marie Herr; Helene Grondin; Stéphane Sanchez; Didier Armaingaud; Caroline Blochet; Antoine Vial; Philippe Denormandie; Joël Ankri
Journal:  Eur J Clin Pharmacol       Date:  2017-01-16       Impact factor: 2.953

4.  Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system.

Authors:  B Bongue; M L Laroche; S Gutton; A Colvez; R Guéguen; J J Moulin; L Merle
Journal:  Eur J Clin Pharmacol       Date:  2011-06-21       Impact factor: 2.953

Review 5.  Inappropriate drug prescriptions among older nursing home residents: the Italian perspective.

Authors:  Carmelinda Ruggiero; Fabrizia Lattanzio; Giuseppina Dell'Aquila; Beatrice Gasperini; Antonio Cherubini
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

6.  Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!

Authors:  François Montastruc; Virginie Gardette; Christelle Cantet; Antoine Piau; Maryse Lapeyre-Mestre; Bruno Vellas; Jean-Louis Montastruc; Sandrine Andrieu
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

7.  Health status and drug use 1 year before and 1 year after skilled nursing home admission during the first quarter of 2013 in France: a study based on the French National Health Insurance Information System.

Authors:  Alice Atramont; Dominique Bonnet-Zamponi; Isabelle Bourdel-Marchasson; Isabelle Tangre; Anne Fagot-Campagna; Philippe Tuppin
Journal:  Eur J Clin Pharmacol       Date:  2017-10-03       Impact factor: 2.953

8.  Potentially inappropriate prescribing in patients on admission and discharge from an older peoples' unit of an acute UK hospital.

Authors:  Raliat Onatade; Vivian Auyeung; Greg Scutt; Jasmine Fernando
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

Review 9.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Audrey Rankin; Cathal A Cadogan; Susan M Patterson; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes
Journal:  Cochrane Database Syst Rev       Date:  2018-09-03

10.  Medication management for people with dementia in primary care: description of implementation in the DelpHi study.

Authors:  Thomas Fiß; Jochen René Thyrian; Diana Wucherer; Grit Aßmann; Ingo Kilimann; Stefan J Teipel; Wolfgang Hoffmann
Journal:  BMC Geriatr       Date:  2013-11-13       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.